TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Liminatus Pharma ( (LIMN) ) has provided an announcement.
On July 16, 2025, Liminatus Pharma, Inc. entered into a settlement agreement with Alta Partners, LLC, where the company agreed to issue 350,000 shares of its common stock in exchange for the cancellation of 1,000,000 warrants held by Alta Partners. This strategic move, involving no commission or remuneration, reflects Liminatus Pharma’s efforts to manage its equity structure and could have implications for its stock valuation and investor relations.
More about Liminatus Pharma
Average Trading Volume: 334,519
Technical Sentiment Signal: Sell
Current Market Cap: $145.4M
Learn more about LIMN stock on TipRanks’ Stock Analysis page.